Author: ["Peter A. Kreuzaler","Anna D. Staniszewska","Wenjing Li","Nader Omidvar","Blandine Kedjouar","James Turkson","Valeria Poli","Richard A. Flavell","Richard W. E. Clarkson","Christine J. Watson"]
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Post-lactational involution in the mammary gland is shown to be accomplished by a lysosome-mediated cell death pathway. This pathway is independent of the executioner caspases 3, 6 and 7, and instead relies on Stat3-mediated upregulation of cathepsins. It is well established that lysosomes play an active role during the execution of cell death1. A range of stimuli can lead to lysosomal membrane permeabilization (LMP), thus inducing programmed cell death without involvement of the classical apoptotic programme2,3. However, these lysosomal pathways of cell death have mostly been described in vitro or under pathological conditions4,5,6,7. Here we show that the physiological process of post-lactational regression of the mammary gland is accomplished through a non-classical, lysosomal-mediated pathway of cell death. We found that, during involution, lysosomes in the mammary epithelium undergo widespread LMP. Furthermore, although cell death through LMP is independent of executioner caspases 3, 6 and 7, it requires Stat3, which upregulates the expression of lysosomal proteases cathepsin B and L, while downregulating their endogenous inhibitor Spi2A (ref. 8). Our findings report a previously unknown, Stat3-regulated lysosomal-mediated pathway of cell death under physiological circumstances. We anticipate that these findings will be of major importance in the design of treatments for cancers such as breast, colon and liver, where cathepsins and Stat3 are commonly overexpressed and/or hyperactivated respectively1,9,10.Cite this article
Kreuzaler, P., Staniszewska, A., Li, W. et al. Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 13, 303–309 (2011). https://doi.org/10.1038/ncb2171 